MiWEndo
Financiado
REVOLUTIONARY ELECTROMAGNETIC ENDOSCOPY ACCESSORY TO AUTOMATIZE POLYP DETECTION
Every year 1,4 million new cases of colorectal cancer (CRC) are diagnosed. Polyps and early-stage CRCs are usually asymptomatic or have symptoms that can be easily confused with other mild ailments. This cancer can be cured in mor...
Every year 1,4 million new cases of colorectal cancer (CRC) are diagnosed. Polyps and early-stage CRCs are usually asymptomatic or have symptoms that can be easily confused with other mild ailments. This cancer can be cured in more than 90% of cases if precancerous polyps are detected and removed. Colonoscopy is the most effective method to remove polyps in the entire colon. However, 8% of CRCs are diagnosed after a negative colonoscopy, and 22% of polyps are not detected due to visual limitations of the colonoscope camera. MiWEndo Solutions is a medical device startup focused on bringing innovative technologies to practical diagnosis of diseases related with tumor processes. Its first product is MiWEndo, a low cost and safe electromagnetic device designed to be attached to the tip of a conventional colonoscope. MiWEndo automatizes polyp detection emitting an alarm when a polyp is sensed, increases the field of view to 360º and provides quantitative differentiation between malignant and benign polyps without changing current clinical practice. Its core technology is based on microware imaging, and we have developed algorithms that can differentiate between healthy colon mucosa, cancer, and different histological types of polyps based on their dielectric properties. Our technology is protected with European patent EP3195786A1. After CRC detection, additional applications of our technology will include other bowel disorders. We have a financial need of 3,8 M€ between 2020 and 2023 (product launch). Of these, 1,5 M€ will be provided as a grant from the European Commission within the EIC Accelerator Program (2020-2022), corresponding to 70% of the project budget. At the end of the project MiWEndo will have reached TRL8, including a clinical validation in a clinical trial, and will have obtained CE mark and FDA approval prior to product launch in early markets.
ver más
Duración del proyecto: 39 meses
Fecha Inicio: 2020-09-21
Fecha Fin: 2023-12-31
Fecha Fin: 2023-12-31
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2023-12-31
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
2M€
Líder del proyecto
MIWENDO SOLUTIONS
Desarrollar, fabricar y comercializar soluciones basadas en el uso de las ondas electromagneticas en el rango de las microondas con finalida...
Perfil tecnológico
TRL
4-5
260K
Perfil tecnológico
TRL
4-5
260K